NASDAQ:ALNA

Allena Pharmaceuticals Earning Date

USA |NASDAQ |USD

ALNA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.18 $-0.24 $-0.22
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $0.00 $0.00 $0.00

Allena Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

ALNA Earnings Date & History Chart

ALNA Earnings & Revenue Forecast

ALNA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.19 $-0.21 $-0.15
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.81 $-0.84 $-0.75
Dec 2022 4 $-0.71 $-0.75 $-0.66

ALNA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.19 $-0.19 $-0.21
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.81 $-0.78 $-0.83
Dec 2022 0 / 0 $-0.71 $-0.70 $-0.98

ALNA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Dec 2022 4 $2.50M $0.00 $10.00M

ALNA Earnings Date & Revenue History

ALNA Earnings History

|
Show More
Show More

ALNA Revenue History

|
Show More
Show More

Allena Pharmaceuticals Next Earnings Date & Report

ALNA Next Earnings Date & Report Preview: Sep 2021 (FQ)

ALNA's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Allena Pharmaceuticals's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.19, and a high estimation of $-0.18.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.18, and the 3 month trend is $-0.21.

Based on 4 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Allena Pharmaceuticals Previous Earnings Dates & Reports

ALNA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Allena Pharmaceuticals's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

ALNA's earnings per share (EPS) was $-0.24, missing the consensus analysts forecast of $-0.20 by -20.00%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 14.29%, and higher than the same period a year before (Jun 2020) by -7.69%.

Revenues were $0.00.

The company reported a net income of $-13.97M.

Free cash flow for the quarter was $-11.40M , compared to $-10.46M last quarter and $-6.72M a year before.

ALNA ended the quarter with $10.52M in total debt, an increase of 0.45% compared to the previous quarter, and an increase of 27.07% compared to the same quarter a year before.

ALNA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Allena Pharmaceuticals's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

ALNA's earnings per share (EPS) was $-1.03, missing the consensus analysts forecast of $-0.94 by 9.57% , and higher than the previous year's EPS (Dec 2019) by -51.36%.

Revenues were $0.00.

The company reported a net income of $-32.84M.

Allena Pharmaceuticals reported a free cash flow of $-28.81M for its fiscal year, compared to $-43.75M a year ago.

The company ended the fiscal year with $10.14M in total debt, a decrease of -3.19% compared to the previous year.